Major Drug Class | Patients, n (%) | Drug name | n (%) |
---|---|---|---|
Anti-platelets | 156 (86.7%) | Aspirin | 130 (48.3%) |
 |  | Clopidogrel | 91 (33.8%) |
 |  | Glyprin | 25 (9.3%) |
 |  | Others | 23 (8.6%) |
Statins | 152 (84.4%) | Simvastatin | 99 (59.3%) |
 |  | Atorvastatin | 68 (40.7%) |
Proton pump inhibitors | 136 (75.6%) | Pantoprazole | 134 (96.4%) |
 |  | Omeprazole | 5 (3.6%) |
Anti-diabetic | 73 (40.5%) | Metformin | 55 (42.3%) |
 |  | Actrapid | 28 (21.5%) |
 |  | Gliclazide | 24 (18.5%) |
 |  | Others | 23 (17.7&) |
Anti-hypertensive | 65 (36.1%) | Perindopril | 61 (88.4%) |
 |  | Losartan | 3 (4.3%) |
 |  | Telmisartan | 2 (2.9%) |
 |  | Others | 3 (4.3%) |
Anti-infective | 35 (19.4%) | Amoxicillin | 23 (36.5%) |
 |  | Ampicillin | 9 (14.2%) |
 |  | Carbapenem | 6 (9.5%) |
 |  | Ceftazidime | 4 (6.3%) |
 |  | Others | 21 (33.3%) |